January 16, 2020
Japan Tobacco has acquired the Japan rights to tapinarof, an investigational psoriasis and atopic dermatitis treatment being developed by Dermavant Sciences, a dermatology unit of Roivant Sciences, the two companies said in separate statements on January 15. Under the deal,...read more